Proxy Votes Now

Home › Funds › Equitable › EQ/Small Company Index Portfolio

EQ/Small Company Index Portfolio proxy voting record 2025-2026

Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000009197

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 15,261 with, 55 against, 188 abstentions (not counted as with management); 4 items carried no recommendation. Shareholder proposals: 29 FOR, 15 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Equitable as a whole

The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsEquitableItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)79.1%14,96292.5%339,726
Backed environmental and social shareholder proposals at US companiesn/a69.6%3,486

Where this fund voted differently from most Equitable funds

Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Equitable funds on 2,747 items (18.0% of the 15,280 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
Denny's Corporation2026-01-13To approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to the Company's named executive officers that is based on or otherwise relates to the Merger.AgainstFOR — 8 of 8 Equitable fundsAgainstPassed (calculated), 93.5% support
Anterix Inc.2025-08-05To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.AgainstFOR — 7 of 7 Equitable fundsAgainstApproved, 84.0% support
Phathom Pharmaceuticals, Inc.2026-05-19To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Mark StenhouseWithholdFOR — 7 of 7 Equitable fundsAgainstElected, 87.5% support
Phathom Pharmaceuticals, Inc.2026-05-19To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Theodore R. SchroederWithholdFOR — 7 of 7 Equitable fundsAgainstElected, 90.3% support
Aehr Test Systems2025-10-20Election of Directors: Rhea J. PosedelForWITHHOLD — 6 of 6 Equitable fundsForElected, 92.7% support
Anterix Inc.2025-08-05To elect seven directors to hold office until the 2026 Annual Meeting of Stockholders and until their respective successors are elected and qualified: Mahvash YazdiAgainstFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 94.4% support
MarineMax, Inc.2026-03-03Election of Directors: To elect three directors, each to serve for a three-year term expiring at the 2029 annual meeting of shareholders and until the election and qualification of their respective successors in office: William Brett McGillAgainstFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 76.6% support
MarineMax, Inc.2026-03-03To approve the amendment of our 2021 Stock-Based Compensation Plan to increase the number of shares available for issuance by 415,000 shares.AgainstFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 89.4% support
Verastem, Inc.2026-05-21Election of Directors: Karin TollefsonWithholdFOR — 6 of 6 Equitable fundsAgainstElected, 92.4% support
Latham Group, Inc.2026-04-30Election of Class II Directors: Frank J. DellaquilaWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 86.7% support
Latham Group, Inc.2026-04-30Election of Class II Directors: William M. PruellageWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 81.8% support
ORIC Pharmaceuticals, Inc.2026-06-18To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Mardi C. DierWithholdFOR — 6 of 6 Equitable fundsAgainstElected, 91.4% support
Daily Journal Corporation2026-02-24Election of four Directors: John B. FrankAgainstFOR — 6 of 6 Equitable fundsAgainstElected, 97.5% support
Daily Journal Corporation2026-02-24Election of four Directors: Mary ConlinAgainstFOR — 6 of 6 Equitable fundsAgainstElected, 95.1% support
Daily Journal Corporation2026-02-24Election of four Directors: Rasool RayaniAgainstFOR — 6 of 6 Equitable fundsAgainstElected, 97.3% support
Aebi Schmidt Holding AG2026-05-21Election of the Board of Directors and the Chair of the Board of Directors Election of the Board of Directors: Patrick SchaubAgainstFOR — 6 of 6 Equitable fundsAgainst—
Aebi Schmidt Holding AG2026-05-21Election of the Human Resources and Compensation Committee of the Board of Directors: Patrick SchaubAgainstFOR — 6 of 6 Equitable fundsAgainst—
Bowman Consulting Group Ltd.2026-05-28Election of the two Class II directors nominated by our Board of Directors and named in the proxy statement to serve for three-year terms expiring at the 2029 Annual Meeting of Stockholders: Patricia MulroyWithholdFOR — 6 of 6 Equitable fundsAgainstElected, 53.3% support
Bowman Consulting Group Ltd.2026-05-28Election of the two Class II directors nominated by our Board of Directors and named in the proxy statement to serve for three-year terms expiring at the 2029 Annual Meeting of Stockholders: Virginia GrebbienWithholdFOR — 6 of 6 Equitable fundsAgainstElected, 59.8% support
Ginkgo Bioworks Holdings, Inc.2026-06-11Election of Directors: Harry E. SloanAgainstFOR — 6 of 6 Equitable fundsAgainstElected, 90.0% support
Ginkgo Bioworks Holdings, Inc.2026-06-11Election of Directors: Ross FubiniAgainstFOR — 6 of 6 Equitable fundsAgainstElected, 92.6% support
Ginkgo Bioworks Holdings, Inc.2026-06-11Election of Directors: Sri KosuriAgainstFOR — 6 of 6 Equitable fundsAgainstElected, 92.2% support
Wave Life Sciences Ltd.2025-08-05To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.AgainstFOR — 6 of 6 Equitable fundsAgainstApproved, 78.2% support
Investors Title Company2026-05-20Election of Directors: Tammy F. ColeyWithholdFOR — 6 of 6 Equitable fundsAgainstElected, 84.3% support
Investors Title Company2026-05-20Election of Directors: W. Morris FineWithholdFOR — 6 of 6 Equitable fundsAgainstElected, 90.9% support
Show the next 475
Items 26 to 500.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
Aquestive Therapeutics, Inc.2026-06-10To elect Gregory B. Brown, M.D., John S. Cochran and Abigail L. Jenkins as Class II members of the Board of Directors, each to serve for a three-year term until the Company's 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Abigail L. JenkinsWithholdFOR — 6 of 6 Equitable fundsAgainst—
Aquestive Therapeutics, Inc.2026-06-10To elect Gregory B. Brown, M.D., John S. Cochran and Abigail L. Jenkins as Class II members of the Board of Directors, each to serve for a three-year term until the Company's 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: John S. CochranWithholdFOR — 6 of 6 Equitable fundsAgainst—
Genie Energy Ltd.2026-06-10Election of Directors: Alan RosenthalAgainstFOR — 6 of 6 Equitable fundsAgainstElected, 95.2% support
Genie Energy Ltd.2026-06-10Election of Directors: Joyce J. MasonAgainstFOR — 6 of 6 Equitable fundsAgainstElected, 99.8% support
Genie Energy Ltd.2026-06-10Election of Directors: W. Wesley PerryAgainstFOR — 6 of 6 Equitable fundsAgainstElected, 95.5% support
908 Devices Inc.2026-06-11To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.AgainstFOR — 6 of 6 Equitable fundsAgainstApproved, 88.5% support
908 Devices Inc.2026-06-11To elect three Class III directors to hold office until the 2029 annual meeting of stockholders: Christopher Brown, Ph.D.WithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 99.2% support
908 Devices Inc.2026-06-11To elect three Class III directors to hold office until the 2029 annual meeting of stockholders: E. Kevin HrusovskyWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 87.0% support
908 Devices Inc.2026-06-11To elect three Class III directors to hold office until the 2029 annual meeting of stockholders: Keith L. CrandellWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 98.6% support
Quad/Graphics, Inc.2026-05-20Election of Directors: Beth-Ann EasonWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 94.1% support
Quad/Graphics, Inc.2026-05-20Election of Directors: Christopher B. HarnedWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 94.2% support
Quad/Graphics, Inc.2026-05-20Election of Directors: Jay O. RothmanWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 94.7% support
Quad/Graphics, Inc.2026-05-20Election of Directors: Kathryn Quadracci FloresWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 94.1% support
Quad/Graphics, Inc.2026-05-20Election of Directors: Melanie A. HuetWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 93.0% support
Quad/Graphics, Inc.2026-05-20Election of Directors: Stephen M. FullerWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 93.0% support
Tectonic Therapeutic, Inc.2026-06-08Advisory approval of the compensation of the Company's Named Executive Officers.AgainstFOR — 6 of 6 Equitable fundsAgainstApproved, 99.2% support
Natural Gas Services Group, Inc.2026-06-10Election of Directors: J. Anthony Gallegos, Jr.AgainstFOR — 6 of 6 Equitable fundsAgainstElected, 96.6% support
Mayville Engineering Company, Inc.2026-04-21Election of Directors: Terms expiring at the 2029 Annual Meeting: Robert L. McCormickWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 61.8% support
Fennec Pharmaceuticals Inc.2026-06-102026 EQUITY INDUCEMENT PLAN To consider, and if deemed advisable, ratify and approve the adoption of Fennec's 2026 Equity Inducement Plan.AgainstFOR — 6 of 6 Equitable fundsAgainstApproved, 94.7% support
Fennec Pharmaceuticals Inc.2026-06-10AMENDMENT TO 2020 EQUITY INCENTIVE PLAN To consider, and if deemed advisable, approve an increase in the number of Common Shares which are reserved for issuance under Fennec's 2020 Equity Incentive Plan.AgainstFOR — 6 of 6 Equitable fundsAgainstApproved, 92.4% support
indie Semiconductor, Inc.2026-05-28To elect three Class II directors for terms expiring at the 2029 Annual Meeting of Stockholders: Diane BiagiantiWithholdFOR — 6 of 6 Equitable fundsAgainstElected, 84.6% support
indie Semiconductor, Inc.2026-05-28To elect three Class II directors for terms expiring at the 2029 Annual Meeting of Stockholders: Diane BrinkWithholdFOR — 6 of 6 Equitable fundsAgainstElected, 83.6% support
indie Semiconductor, Inc.2026-05-28To elect three Class II directors for terms expiring at the 2029 Annual Meeting of Stockholders: Karl-Thomas NeumannWithholdFOR — 6 of 6 Equitable fundsAgainstElected, 98.4% support
Tredegar Corporation2026-05-08Non-Binding Advisory Vote to Approve Named Executive Officer Compensation.AgainstFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 56.9% support
The Lovesac Company2026-06-09Election of Directors: Sharon LeiteWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 85.7% support
The Lovesac Company2026-06-09To provide advisory approval of the Company's fiscal 2026 compensation for its named executive officers.AgainstFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 72.5% support
Abeona Therapeutics Inc.2026-06-12To approve an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 8,400,000 to 11,500,000.AgainstFOR — 6 of 6 Equitable fundsAgainstApproved, 80.7% support
Abeona Therapeutics Inc.2026-06-12To approve, on an advisory basis, the compensation of the Company's named executive officers.AgainstFOR — 6 of 6 Equitable fundsAgainstApproved, 83.8% support
RCI Hospitality Holdings, Inc.2025-08-18ELECTION OF DIRECTORS OF THE COMPANY: Travis ReeseWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 97.8% support
TriSalus Life Sciences, Inc.2026-05-14To elect the Board's two nominees for directors named as nominees in the Proxy Statement to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation, or removal: Gary GordonWithholdFOR — 6 of 6 Equitable fundsAgainstElected, 92.2% support
TriSalus Life Sciences, Inc.2026-05-14To elect the Board's two nominees for directors named as nominees in the Proxy Statement to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation, or removal: Mary SzelaWithholdFOR — 6 of 6 Equitable fundsAgainstElected, 92.3% support
Expensify, Inc.2026-05-22Approval, on an advisory basis, of the compensation of our named executive officers.AgainstFOR — 6 of 6 Equitable fundsAgainstApproved, 97.9% support
Expensify, Inc.2026-05-22Election of Directors: Carlos Alvarez DivoWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 95.4% support
Expensify, Inc.2026-05-22Election of Directors: Daniel VidalWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 95.3% support
Expensify, Inc.2026-05-22Election of Directors: Jason MillsWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 95.3% support
Bakkt, Inc.2026-04-17To adjourn the Special Meeting, if necessary or appropriate in the view of the board of directors, including to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to adopt Proposal 1.AbstainFOR — 6 of 6 Equitable fundsAgainst—
Bakkt, Inc.2026-04-17To approve the issuance of shares in accordance with Sections 312.03(b), 312.03(c), and 312.03(d) of the New York Stock Exchange Listed Company Manual.AbstainFOR — 6 of 6 Equitable fundsAgainst—
Vuzix Corporation2026-06-16To conduct a non-binding advisory vote for the approval of the compensation disclosed in the Proxy Statement of the Company's executive officers who are named in the Proxy Statement Summary Compensation Table.AgainstFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 80.5% support
CSP Inc.2026-02-10Election of Directors: Anthony FolgerWithholdFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 95.9% support
Inseego Corp.2026-06-16Approve, in an advisory vote, the compensation paid to the Company's named executive officers, as presented in the proxy statementAgainstFOR — 6 of 6 Equitable fundsAgainstApproved, 81.0% support
Inseego Corp.2026-06-16Elect two directors to serve until the 2029 Annual Meeting of Stockholders.: Jeffrey TuderWithholdFOR — 6 of 6 Equitable fundsAgainstElected, 85.1% support
Cardiff Oncology, Inc.2026-06-11Proposal to approve an amendment to the Company's 2021 Omnibus Equity Incentive Plan to increase the number of shares issuable thereunder to 15,150,000 shares from 12,150,000 shares.AgainstFOR — 6 of 6 Equitable fundsAgainstApproved, 57.1% support
Neonode Inc.2026-06-17Election of Nominees for Class III Directors: Per LofgrenWithholdFOR — 6 of 6 Equitable fundsAgainst—
Aeluma, Inc.2026-01-15To re-elect the Class I directors named in this Proxy Statement to hold office for a 3-year term and until his respective successor is elected and duly qualified: Steven P. DenBaarsWithholdFOR — 6 of 6 Equitable fundsAgainst—
Airship AI Holdings, Inc.2025-12-11Election of Directors: Amit MitalWithholdFOR — 6 of 6 Equitable fundsAgainst—
Airship AI Holdings, Inc.2025-12-11Election of Directors: Louis LebedinForWITHHOLD — 6 of 6 Equitable fundsFor—
American Battery Technology Company2025-11-13To elect five directors to the Company's Board of Directors (the "Board") to serve until their respective successors are duly elected and qualified: Rick FezellWithholdFOR — 6 of 6 Equitable fundsAgainst—
Aura Biosciences, Inc.2026-06-11To elect two Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: David JohnsonWithholdFOR — 6 of 6 Equitable fundsAgainst—
Aura Biosciences, Inc.2026-06-11To elect two Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Teresa Marie BitettiWithholdFOR — 6 of 6 Equitable fundsAgainst—
BETA Technologies, Inc.2026-06-11Election of Directors: General (RET) James McConvilleWithholdFOR — 6 of 6 Equitable fundsAgainst—
BETA Technologies, Inc.2026-06-11Election of Directors: John AbeleWithholdFOR — 6 of 6 Equitable fundsAgainst—
BETA Technologies, Inc.2026-06-11Election of Directors: John SlatteryWithholdFOR — 6 of 6 Equitable fundsAgainst—
European Wax Center, Inc.2026-05-07A proposal to approve and adopt the Agreement and Plan of Merger (as it may be amended, supplemented or modified from time to time), dated as of February 9, 2026, by and among Glow Midco, LLC, a Delaware limited liability company ("Parent"), Glow Merger Sub 1, Inc., a Delaware corporation and a wholAbstainFOR — 6 of 6 Equitable fundsAgainst—
European Wax Center, Inc.2026-05-07A proposal to approve one or more proposals to adjourn the Special Meeting, if necessary or appropriate, including adjournments to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Merger Agreement Proposal (the "Adjournment Proposal").AbstainFOR — 6 of 6 Equitable fundsAgainst—
Flushing Financial Corporation2026-04-02A proposal to approve, on a non-binding, advisory basis, the compensation that Flushing's named executive officers may receive in connection with the mergers pursuant to agreements or arrangements with Flushing (the "Flushing compensation proposal")AgainstFOR — 6 of 6 Equitable fundsAgainst—
Golden Entertainment, Inc.2026-03-31To consider and vote on a proposal to approve one or more adjournments of the Special Meeting, from time to time, to a later date or dates to solicit additional proxies if there are insufficient votes to adopt the Transaction Proposal at the time of the Special Meeting (the "Adjournment Proposal").AbstainFOR — 6 of 6 Equitable fundsAgainstApproved, 94.7% support
Hingham Institution for Savings2026-04-30To elect five Class II Directors named in the proxy statement, each to serve until the 2029 Annual Meeting of Stockholders, and until his or her respective successor is duly elected and qualified: Brian T. KennerWithholdFOR — 6 of 6 Equitable fundsAgainst—
Hingham Institution for Savings2026-04-30To elect five Class II Directors named in the proxy statement, each to serve until the 2029 Annual Meeting of Stockholders, and until his or her respective successor is duly elected and qualified: Geoffrey C. Wilkinson, Sr.WithholdFOR — 6 of 6 Equitable fundsAgainst—
Hingham Institution for Savings2026-04-30To elect five Class II Directors named in the proxy statement, each to serve until the 2029 Annual Meeting of Stockholders, and until his or her respective successor is duly elected and qualified: Patrick R. GaughenWithholdFOR — 6 of 6 Equitable fundsAgainst—
Innventure, Inc.2026-06-17Election of three Class II directors, Bruce Brown, James O. Donnally and Catriona Fallon, as recommended by the Nominating and Corporate Governance Committee, each being nominated to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Bruce BrownWithholdFOR — 6 of 6 Equitable fundsAgainst—
Kolibri Global Energy Inc.2026-05-04Re-approve Stock Option PlanAgainstFOR — 6 of 6 Equitable fundsAgainst—
LifeMD, Inc.2026-06-12Elect seven directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified: Dr. Joan LaRovere, M.D.WithholdFOR — 6 of 6 Equitable fundsAgainst—
LifeMD, Inc.2026-06-12To approve LifeMD's Fourth Amended and Restated 2020 Equity and Incentive Plan.AgainstFOR — 6 of 6 Equitable fundsAgainst—
LifeMD, Inc.2026-06-12To authorize the Chairman of the Board to adjourn the Annual Meeting to a later date, if necessary or appropriate, including for purposes of soliciting additional votes in favor of any or all of the proposals or for purposes of establishing a quorum.AgainstFOR — 6 of 6 Equitable fundsAgainst—
Lucid Diagnostics Inc.2026-06-24Election of Class B Directors: Ronald M. SparksWithholdFOR — 6 of 6 Equitable fundsAgainst—
Marine Products Corporation2026-05-12To adjourn the Marine Products Special Meeting from time to time, if deemed by the chair of the Marine Products Special Meeting to be necessary or appropriate, including to solicit additional proxies in the event there are not sufficient votes at the time of the Marine Products Special Meeting to apAbstainFOR — 6 of 6 Equitable fundsAgainst—
Marine Products Corporation2026-05-12To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to the named executive officers of Marine Products in connection with the transactions contemplated by the merger agreement.AgainstFOR — 6 of 6 Equitable fundsAgainst—
Performant Healthcare, Inc.2025-10-17Non-Binding, Advisory Vote on Named Executive Officers Merger-Related CompensationAgainstFOR — 6 of 6 Equitable fundsAgainst—
Piedmont Lithium Inc.2025-08-22To adopt the Agreement and Plan of Merger, dated as of November 18, 2024 (as it may be further amended from time to time, the "merger agreement"), by and among Sayona Mining Limited, Shock MergeCo Inc., and Piedmont Lithium Inc.AbstainFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 97.7% support
Piedmont Lithium Inc.2025-08-22To postpone or adjourn the Special Meeting, from time to time, to a later date or dates, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes to adopt the merger agreement at the time of the Special Meeting.AbstainFOR — 6 of 6 Equitable fundsAgainstPassed (calculated), 93.2% support
Satellogic Inc.2026-06-03Election of Directors: Miguel GutierrezWithholdFOR — 6 of 6 Equitable fundsAgainst—
SunPower, Inc.2026-03-25To approve, for purposes of complying with Nasdaq Listing Rule 5635(a), the issuance of shares of the Company's Common Stock as post-closing pursuant to the Membership Interest Purchase Agreement, dated as of November 21, 2025, by and among SunPower Inc., Ambia Holdings, Inc. and Ambia Energy, LLC iAgainstFOR — 6 of 6 Equitable fundsAgainst—
Synchronoss Technologies, Inc.2026-02-12To adjourn the Special Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the special meeting of stockholders of Synchronoss.AbstainFOR — 6 of 6 Equitable fundsAgainst—
Synchronoss Technologies, Inc.2026-02-12To approve the adoption of the Agreement and Plan of Merger (as it may be amended from time to time), dated December 3, 2025, by and among Synchronoss Technologies, Inc. ("Synchronoss"), Lumine Group US Holdco Inc. ("Parent") and Skyfall Merger Sub Inc. ("Merger Sub"), pursuant to which Merger Sub wAbstainFOR — 6 of 6 Equitable fundsAgainst—
Tango Therapeutics, Inc.2026-06-04Election of Class II Directors: Mace Rothenberg, M.D.WithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 79.8% support
MBX Biosciences, Inc.2026-06-04Election of two Class II Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders or until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Patrick J. HeronWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 88.4% support
The Buckle, Inc.2026-06-01Election of Directors: Karen B. RhoadsForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 69.8% support
Flowco Holdings Inc.2026-05-07The election of two Class I directors to serve until the 2029 Annual Meeting of Stockholders and until his/her successors are duly elected and qualified: Cynthia L. WalkerWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 99.5% support
Sonida Senior Living, Inc.2026-02-26Proposal to approve an amendment to the Amended and Restated Certificate of Incorporation of SNDA, as amended (the "SNDA Charter"), to increase the number of shares of SNDA Common Stock that SNDA is authorized to issue from 30,000,000 to 100,000,000 shares, in the form attached as Annex D (the "AuthAbstainFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 99.1% support
Sonida Senior Living, Inc.2026-02-26Proposal to approve the adjournment of the SNDA Special Meeting, if necessary, to permit the solicitation of additional proxies in the event that there are insufficient votes on the Authorized Share Increase Proposal and the Stock Issuance Proposal presented to SNDA stockholders (the "SNDA AdjournmeAbstainFOR — 5 of 5 Equitable fundsAgainst—
Sonida Senior Living, Inc.2026-02-26Proposal to approve the issuance of shares of SNDA Common Stock to (i) holders of CHP common stock pursuant to the Merger Agreement, and (ii) certain affiliates of Conversant Capital LLC and Silk Partners, LP ("Silk"), pursuant to certain investment agreements entered into by SNDA in connection withAbstainFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 100.0% support
Nurix Therapeutics, Inc.2026-05-15Election of Class III Directors: Arthur T. Sands, M.D., Ph.D.WithholdFOR — 5 of 5 Equitable fundsAgainstElected, 79.6% support
Nurix Therapeutics, Inc.2026-05-15Election of Class III Directors: Paul M. SilvaWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 74.2% support
Atlanticus Holdings Corporation2026-05-07To elect seven directors for terms expiring at the 2027 Annual Meeting of Shareholders: David G. HannaWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 100.0% support
Atlanticus Holdings Corporation2026-05-07To elect seven directors for terms expiring at the 2027 Annual Meeting of Shareholders: Jeffrey A. HowardWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 100.0% support
Pursuit Attractions & Hospitality, Inc.2026-06-04Elect two Class I directors, to serve until the 2029 annual meeting of shareholders: Jill H. BrightAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 79.5% support
Pursuit Attractions & Hospitality, Inc.2026-06-04Elect two Class I directors, to serve until the 2029 annual meeting of shareholders: Joshua E. SchechterAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.0% support
Tyra Biosciences, Inc.2026-05-28To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Habib J. DableWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.9% support
Tyra Biosciences, Inc.2026-05-28To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert MoreWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 91.7% support
Tyra Biosciences, Inc.2026-05-28To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Susan Moran, M.D., M.S.C.E.WithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 99.6% support
Rapport Therapeutics, Inc.2026-06-10To elect James Healy, M.D., Ph.D., Robert J. Perez, and Raymond Sanchez, M.D. as Class II Directors: Robert J. PerezWithholdFOR — 5 of 5 Equitable fundsAgainst—
Allient Inc.2026-05-06TO ELECT SIX DIRECTORS TO HOLD OFFICE UNTIL THE NEXT ANNUAL MEETING OF SHAREHOLDERS: M.R. WinterAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.0% support
Allient Inc.2026-05-06TO ELECT SIX DIRECTORS TO HOLD OFFICE UNTIL THE NEXT ANNUAL MEETING OF SHAREHOLDERS: N.R. TzetzoAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.9% support
Allient Inc.2026-05-06TO ELECT SIX DIRECTORS TO HOLD OFFICE UNTIL THE NEXT ANNUAL MEETING OF SHAREHOLDERS: R.B. EngelAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 99.6% support
Allient Inc.2026-05-06TO ELECT SIX DIRECTORS TO HOLD OFFICE UNTIL THE NEXT ANNUAL MEETING OF SHAREHOLDERS: R.D. FedericoAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 97.5% support
Allient Inc.2026-05-06TO ELECT SIX DIRECTORS TO HOLD OFFICE UNTIL THE NEXT ANNUAL MEETING OF SHAREHOLDERS: S.C. FinchAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 99.4% support
CRA International, Inc.2025-07-17To consider and vote upon the election of two Class III Directors: Paul MalehWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.1% support
CRA International, Inc.2025-07-17To consider and vote upon the election of two Class III Directors: Thomas AveryWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.4% support
UroGen Pharma Ltd.2026-06-22To approve the amendment and restatement of the Articles of Association of the Company to, among other things, tie eligibility for shareholder proposals to the requirements under the Israeli Companies Law.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 68.2% support
UroGen Pharma Ltd.2026-06-22To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Arie Belldegrun, M.D.ForAGAINST — 5 of 5 Equitable fundsForElected, 82.5% support
Omeros Corporation2026-06-18Approval of the Amended and Restated Omeros Corporation Omnibus Incentive Compensation Plan.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 61.1% support
Omeros Corporation2026-06-18Election of Directors: Thomas J. CableAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 66.4% support
Bandwidth Inc.2026-05-28To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement;AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 75.5% support
Bandwidth Inc.2026-05-28To elect two Class III directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: David A. MorkenWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 81.9% support
Bandwidth Inc.2026-05-28To elect two Class III directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Rebecca G. BottorffWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 77.8% support
Preformed Line Products Company2026-05-04To elect four directors, each for a term expiring in 2028: J. Ryan RuhlmanAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 100.0% support
Preformed Line Products Company2026-05-04To elect four directors, each for a term expiring in 2028: R. Steven KestnerAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 100.0% support
Metropolitan Bank Holding Corp.2026-04-29Election of Directors: Anthony J. Fabiano - for a 3-year termWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 92.5% support
Metropolitan Bank Holding Corp.2026-04-29Election of Directors: Maria Fiorini Ramirez - for a 3-year termWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 72.4% support
Metropolitan Bank Holding Corp.2026-04-29Election of Directors: Robert C. Patent - for a 3-year termWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 91.6% support
Metropolitan Bank Holding Corp.2026-04-29Election of Directors: William Reinhardt - for a 3-year termWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 92.7% support
Dream Finders Homes, Inc.2026-06-08Approval of the reincorporation of the Company to the State of Texas by conversion.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 95.3% support
Dream Finders Homes, Inc.2026-06-08Election of Directors: Leonard M. SturmAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 96.8% support
Dream Finders Homes, Inc.2026-06-08Election of Directors: Megha H. ParekhAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 95.6% support
Dream Finders Homes, Inc.2026-06-08Election of Directors: Patrick O. ZalupskiAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 98.2% support
Dream Finders Homes, Inc.2026-06-08Election of Directors: William W. WeatherfordAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 98.0% support
Eagle Bancorp, Inc.2026-05-14To approve a non-binding, advisory resolution approving our named executive officer compensation.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 90.6% support
Heritage Insurance Holdings, Inc.2026-06-10Election of Directors: Panagiotis (Pete) ApostolouForWITHHOLD — 5 of 5 Equitable fundsForElected, 82.9% support
Kforce Inc.2026-04-22Approve the Kforce Inc. 2026 Stock Incentive Plan.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 87.9% support
Kforce Inc.2026-04-22Election of Directors: Ann E. DunwoodyAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 91.7% support
Kforce Inc.2026-04-22Election of Directors: Derrick D. BrooksAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 93.0% support
Kforce Inc.2026-04-22Election of Directors: N. John SimmonsAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 93.3% support
Oil-Dri Corporation of America2025-12-09Election of Directors: Allan H. SeligWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 95.1% support
Oil-Dri Corporation of America2025-12-09Election of Directors: Amy L. RyanWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 88.3% support
Oil-Dri Corporation of America2025-12-09Election of Directors: Ellen-Blair ChubeWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 95.0% support
Oil-Dri Corporation of America2025-12-09Election of Directors: George C. RoethWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 95.7% support
Oil-Dri Corporation of America2025-12-09Election of Directors: Lawrence E. WashowWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 95.5% support
Oil-Dri Corporation of America2025-12-09Election of Directors: Michael A. NemeroffWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 94.6% support
Oil-Dri Corporation of America2025-12-09Election of Directors: Patricia J. SchmedaWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 95.7% support
Oil-Dri Corporation of America2025-12-09Election of Directors: Paul M. HindsleyWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 88.4% support
Bumble Inc.2026-06-04Approval, on a non-binding advisory basis, of the compensation of the named executive officers as disclosed in the Proxy Statement.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 94.5% support
Bumble Inc.2026-06-04The election of three Class II directors of Bumble Inc., each to serve a three-year term expiring at the 2029 Annual Meeting of Stockholders and until such director's successor is elected and qualified: Amy M. GriffinWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 97.1% support
Bumble Inc.2026-06-04The election of three Class II directors of Bumble Inc., each to serve a three-year term expiring at the 2029 Annual Meeting of Stockholders and until such director's successor is elected and qualified: R. Lynn AtchisonWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 99.1% support
Bumble Inc.2026-06-04The election of three Class II directors of Bumble Inc., each to serve a three-year term expiring at the 2029 Annual Meeting of Stockholders and until such director's successor is elected and qualified: Sissie L. HsiaoWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 99.2% support
Hippo Holdings Inc.2026-06-02Elect three class II directors for a three-year term: Hugh R. FraterWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 93.2% support
Hippo Holdings Inc.2026-06-02Elect three class II directors for a three-year term: Lori Dickerson FoucheWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 82.4% support
Hippo Holdings Inc.2026-06-02Elect three class II directors for a three-year term: Richard McCathronWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 95.5% support
HealthStream, Inc.2026-05-28To elect three Class II directors (A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: A. Alex JahangirWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 90.3% support
HealthStream, Inc.2026-05-28To elect three Class II directors (A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Linda E. RebrovickWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 93.7% support
Monte Rosa Therapeutics, Inc.2026-06-11To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Andrew Schiff, M.D.WithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 99.0% support
Monte Rosa Therapeutics, Inc.2026-06-11To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Anthony Manning, Ph.D.WithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 79.0% support
Monte Rosa Therapeutics, Inc.2026-06-11To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Chandra P. Leo, M.D.WithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 99.1% support
Petco Health and Wellness Company, Inc.2026-06-30To approve the Second Amendment to the Company's 2021 Equity Incentive Plan to increase the number of shares of Class A Common Stock authorized for issuance under the plan.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 85.0% support
Petco Health and Wellness Company, Inc.2026-06-30To elect the four director nominees named in the proxy statement as Class III directors of the Company, each to serve for a three-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: GarAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 82.9% support
Douglas Dynamics, Inc.2026-04-29Election of Directors: James L. Janik (Term expiring 2028)WithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.0% support
Douglas Dynamics, Inc.2026-04-29Election of Directors: Joher Akolawala (Term expiring 2029)WithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 91.5% support
Rigel Pharmaceuticals, Inc.2026-05-14Election of Directors: Alison Hannah, M.D.AgainstFOR — 5 of 5 Equitable fundsAgainstElected, 86.2% support
Rigel Pharmaceuticals, Inc.2026-05-14Election of Directors: Raul RodriguezAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 98.2% support
Rigel Pharmaceuticals, Inc.2026-05-14Election of Directors: Walter Moos, Ph.D.AgainstFOR — 5 of 5 Equitable fundsAgainstElected, 97.7% support
Rigel Pharmaceuticals, Inc.2026-05-14To approve an amendment to our 2018 Equity Incentive Plan, as amended (the "Amended 2018 Plan"), to add an additional 500,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 63.0% support
OrthoPediatrics Corp.2026-06-04To approve, on an advisory basis, the compensation of our executive officers who are named in the compensation disclosures in this proxy statement.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 84.8% support
OrthoPediatrics Corp.2026-06-04To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: David R. PelizzonWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 95.8% support
OrthoPediatrics Corp.2026-06-04To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: Harald RufWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 95.9% support
Covenant Logistics Group, Inc.2026-05-13Election of Directors: Benjamin S. Carson, Sr.WithholdFOR — 5 of 5 Equitable fundsAgainstElected, 81.5% support
Covenant Logistics Group, Inc.2026-05-13Election of Directors: Bradley A. MolineWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 69.3% support
Covenant Logistics Group, Inc.2026-05-13Election of Directors: D. Michael KramerWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 98.1% support
Covenant Logistics Group, Inc.2026-05-13Election of Directors: David R. ParkerWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 97.8% support
Covenant Logistics Group, Inc.2026-05-13Election of Directors: Herbert J. SchmidtWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 98.3% support
Covenant Logistics Group, Inc.2026-05-13Election of Directors: Joey B. HoganWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 98.5% support
Covenant Logistics Group, Inc.2026-05-13Election of Directors: Rachel Parker-HatchettWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 98.5% support
Covenant Logistics Group, Inc.2026-05-13Election of Directors: Tracy RosserWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 81.5% support
Covenant Logistics Group, Inc.2026-05-13Election of Directors: W. Miller WelbornWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 95.2% support
Nextdoor Holdings, Inc.2026-06-09Election of Class II Director: David SzeWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 97.0% support
Arteris, Inc.2026-06-022 wordings Election of Class II directors whose current terms will expire at the annual meeting of stockholders to be held in 2026: Antonio J. VianaWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 75.2% support
Southern Missouri Bancorp, Inc.2025-10-20Election of Directors: For a term to expire in 2027: Charles R. LoveAgainstFOR — 5 of 5 Equitable fundsAgainst—
Southern Missouri Bancorp, Inc.2025-10-20Election of Directors: For a term to expire in 2028: Daniel L. JonesAgainstFOR — 5 of 5 Equitable fundsAgainst—
Infinity Natural Resources, Inc.2026-06-09To elect eight directors to our Board of Directors: Katherine M. GallagherWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 87.4% support
Forum Energy Technologies, Inc.2026-05-08Election of Directors: Evelyn M. AngelleWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 98.9% support
Forum Energy Technologies, Inc.2026-05-08Election of Directors: John A. CarrigWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 94.7% support
BlackSky Technology Inc.2025-09-10Election of Class I Directors: David DiDomenicoWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 98.1% support
BlackSky Technology Inc.2025-09-10Election of Class I Directors: Magid AbrahamWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 60.9% support
Shore Bancshares, Inc.2026-05-20Election of Directors: David S. Jones Class II (term expires 2029)AgainstFOR — 5 of 5 Equitable fundsAgainstElected, 91.4% support
Shore Bancshares, Inc.2026-05-20Election of Directors: Dawn M. Willey Class II (term expires 2029)AgainstFOR — 5 of 5 Equitable fundsAgainstElected, 94.9% support
Shore Bancshares, Inc.2026-05-20Election of Directors: Louis P. Jenkins, Jr. Class II (term expires 2029)AgainstFOR — 5 of 5 Equitable fundsAgainstElected, 95.0% support
Shore Bancshares, Inc.2026-05-20Election of Directors: Michael B. Adams Class II (term expires 2029)AgainstFOR — 5 of 5 Equitable fundsAgainstElected, 95.7% support
Peoples Financial Services Corp.2026-05-22Election of four directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his successor has been elected and qualified: Joseph CocciaAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 97.6% support
Peoples Financial Services Corp.2026-05-22Election of four directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his successor has been elected and qualified: Joseph L. DeNaples, EsquireAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 97.0% support
Peoples Financial Services Corp.2026-05-22Election of four directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his successor has been elected and qualified: Ronald G. KukuchkaAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.7% support
Peoples Financial Services Corp.2026-05-22Election of four directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his successor has been elected and qualified: Sandra L. BodnykAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 97.9% support
Legacy Housing Corporation2025-12-18Election of Directors: Brian J. FergusonAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 74.8% support
Legacy Housing Corporation2025-12-18Election of Directors: Skyler M. HowtonAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 95.0% support
Arrow Financial Corporation2026-06-03To elect each of the following four (4) persons as Class A directors to a term of three (3) years, each to serve until their successors have been duly elected and qualified: Class A: Daniel J. WhiteWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 87.7% support
Arrow Financial Corporation2026-06-03To elect each of the following four (4) persons as Class A directors to a term of three (3) years, each to serve until their successors have been duly elected and qualified: Class A: Gregory J. ChampionWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 84.1% support
Arrow Financial Corporation2026-06-03To elect each of the following four (4) persons as Class A directors to a term of three (3) years, each to serve until their successors have been duly elected and qualified: Class A: Mark L. BehanWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 94.6% support
Community West Bancshares2026-03-30a proposal to approve the adjournment of the special meeting to permit further solicitation of proxies in the event that an insufficient number of votes are cast to approve the CWB merger proposal (the "CWB adjournment proposal").AbstainFOR — 5 of 5 Equitable fundsAgainstApproved, 98.9% support
Community West Bancshares2026-03-30a proposal to approve the principal terms of the Agreement and Plan of Merger, dated as of December 16, 2025, between CWB and United Security Bancshares ("USB"), pursuant to which USB will merge (the "merger") with and into CWB, and the transactions contemplated therein, including the issuance of CWAbstainFOR — 5 of 5 Equitable fundsAgainstApproved, 99.7% support
Cullinan Therapeutics, Inc.2026-06-16Election of the following individuals nominated to serve as Class III directors, for a three-year term ending at the annual meeting of stockholders to be held in 2029: Nadim AhmedWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 75.6% support
Cullinan Therapeutics, Inc.2026-06-16Election of the following individuals nominated to serve as Class III directors, for a three-year term ending at the annual meeting of stockholders to be held in 2029: Stephen WebsterWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 74.5% support
Capital Bancorp, Inc.2026-05-282 wordings Election of Class III Directors and a Class II Director to serve for terms expiring in 2029 and 2028, respectively (Board unanimously recommends voting FOR all nominees): Nominees (Class III): Jerome R. BaileyAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 75.7% support
CEVA, Inc.2026-06-02To elect seven directors, as specifically set forth in the proxy statement, to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Bernadette AndriettiAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 94.9% support
CEVA, Inc.2026-06-02To elect seven directors, as specifically set forth in the proxy statement, to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Louis SilverAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 95.8% support
CEVA, Inc.2026-06-02To elect seven directors, as specifically set forth in the proxy statement, to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Maria MarcedAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 95.7% support
Natural Grocers by Vitamin Cottage, Inc.2026-03-04Election of Directors: David RooneyForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 85.7% support
Tiptree Inc.2025-12-03A proposal to approve one or more adjournments of the special meeting, if necessary, to solicit additional proxies, in the event that there are insufficient votes to approve the Merger Proposal.ForAGAINST — 5 of 5 Equitable fundsFor—
Tiptree Inc.2025-12-03A proposal to approve the merger and the other transactions contemplated by that certain Agreement and Plan of Merger, dated as of September 26, 2025 (the "Merger Agreement"), among Tiptree Inc., a Maryland corporation, The Fortegra Group, Inc., a Delaware corporation ("Fortegra"), DB Insurance Co.,ForAGAINST — 5 of 5 Equitable fundsForApproved, 80.7% support
Tiptree Inc.2026-04-28Election of three Class I Directors: Bradley E. SmithWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 77.0% support
Tiptree Inc.2026-04-28Election of three Class I Directors: Paul M. FriedmanWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 80.3% support
Tiptree Inc.2026-04-28Election of three Class I Directors: Randy MaultsbyWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 91.3% support
Tiptree Inc.2026-04-28To approve Amendment No. 2 to the 2017 Omnibus Incentive Plan to (a) extend the term of the 2017 Plan to June 6, 2037, and (b) increase the number of shares of the Company's common stock available for awards thereunder by an additional 4,000,000 shares.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 72.8% support
Hovnanian Enterprises, Inc.2026-03-31Approval of the Fourth Amended and Restated 2020 Hovnanian Enterprises, Inc. Stock Incentive Plan.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 91.9% support
Hovnanian Enterprises, Inc.2026-03-31Election of Directors: Edward A. KangasAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 89.3% support
Hovnanian Enterprises, Inc.2026-03-31Election of Directors: J. Larry SorsbyAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 97.9% support
Hovnanian Enterprises, Inc.2026-03-31Election of Directors: Joseph A. MarengiAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 89.2% support
Hovnanian Enterprises, Inc.2026-03-31Election of Directors: Miriam Hernandez-KakolAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 96.3% support
Hovnanian Enterprises, Inc.2026-03-31Election of Directors: Robert B. CouttsAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 94.1% support
Hovnanian Enterprises, Inc.2026-03-31Election of Directors: Robin Stone SellersAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 92.3% support
Hovnanian Enterprises, Inc.2026-03-31Election of Directors: Vincent Pagano Jr.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 86.7% support
Mama's Creations, Inc.2025-07-03To elect five (5) Directors to hold office for a one-year term and until each of their respective successors are duly elected and qualified. The nominees are: Lynn BlakeWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 92.5% support
Olema Pharmaceuticals, Inc.2026-06-17Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Andrew RappaportWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 98.0% support
Olema Pharmaceuticals, Inc.2026-06-17Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Scott GarlandWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 96.4% support
Olema Pharmaceuticals, Inc.2026-06-17Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Yi LarsonWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 73.4% support
IBEX Limited2025-12-05The Election of Directors: Mohammed KhaishgiForAGAINST — 5 of 5 Equitable fundsFor—
Park-Ohio Holdings Corp.2026-05-14Election of Directors: Dan T. Moore IIIWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 89.5% support
Park-Ohio Holdings Corp.2026-05-14Election of Directors: Howard W. Hanna IVWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.3% support
Park-Ohio Holdings Corp.2026-05-14Election of Directors: Patrick V. AulettaWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 97.6% support
Bankwell Financial Group, Inc.2026-05-20Election of Directors: Carl M. PortoForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 85.7% support
Bankwell Financial Group, Inc.2026-05-20Election of Directors: Eric J. DaleForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 89.7% support
Bankwell Financial Group, Inc.2026-05-20Election of Directors: Kevin D. LeitaoForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 89.9% support
Bankwell Financial Group, Inc.2026-05-20Election of Directors: Todd H. LampertForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 89.6% support
EVgo Inc.2026-05-14Election of Directors: Paul SegalWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 94.2% support
Bank7 Corp.2026-05-20Advisory vote on named executive officer compensation.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 99.0% support
ChoiceOne Financial Services, Inc.2026-05-20Election of Directors: Keith D. BrophyWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 92.3% support
ChoiceOne Financial Services, Inc.2026-05-20Election of Directors: Michelle M. WendlingWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 91.8% support
Vishay Precision Group, Inc.2026-05-19Election of Directors: Erez LorberWithholdFOR — 5 of 5 Equitable fundsAgainst—
Vishay Precision Group, Inc.2026-05-19Election of Directors: Kobi AltmanWithholdFOR — 5 of 5 Equitable fundsAgainst—
Vishay Precision Group, Inc.2026-05-19Election of Directors: Nava Swersky SoferWithholdFOR — 5 of 5 Equitable fundsAgainst—
Vishay Precision Group, Inc.2026-05-19Election of Directors: Saul ReibsteinWithholdFOR — 5 of 5 Equitable fundsAgainst—
Vishay Precision Group, Inc.2026-05-19Election of Directors: Sejal Shah GulatiWithholdFOR — 5 of 5 Equitable fundsAgainst—
Vishay Precision Group, Inc.2026-05-19Election of Directors: Ziv ShoshaniWithholdFOR — 5 of 5 Equitable fundsAgainst—
Universal Health Realty Income Trust2026-06-10Election of Trustees: Alan B. MillerAgainstFOR — 5 of 5 Equitable fundsAgainst—
Universal Health Realty Income Trust2026-06-10Election of Trustees: Robert F. McCaddenAgainstFOR — 5 of 5 Equitable fundsAgainst—
Bicara Therapeutics Inc.2026-06-09To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Carolyn Ng, Ph.D.WithholdFOR — 5 of 5 Equitable fundsAgainstElected, 88.3% support
Bicara Therapeutics Inc.2026-06-09To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Christopher Bowden, M.D.WithholdFOR — 5 of 5 Equitable fundsAgainstElected, 90.4% support
OppFi Inc.2026-06-09To approve, on an advisory basis, the 2025 compensation of the Company's named executive officers.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 95.3% support
OppFi Inc.2026-06-09To elect, each for a term expiring at the 2029 Annual Meeting of Stockholders or until a successor has been duly elected and qualified, the following individuals to our Board of Directors: Theodore SchwartzWithholdFOR — 5 of 5 Equitable fundsAgainst—
Orange County Bancorp, Inc.2026-05-26Election of Directors: Marianna R. Kennedy (three-year term)WithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 94.5% support
Orange County Bancorp, Inc.2026-05-26Election of Directors: Richard B. Rowley (three-year term)WithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 96.3% support
Aclaris Therapeutics, Inc.2026-06-04Election of Directors: Anand Mehra, M.D.WithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 89.2% support
Aclaris Therapeutics, Inc.2026-06-04To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 89.5% support
BlueLinx Holdings Inc.2026-05-14Election of Directors: Mitchell B. LewisForAGAINST — 5 of 5 Equitable fundsForFailed (calculated), 43.9% support
BlueLinx Holdings Inc.2026-05-14Proposal to approve an Amendment to the 2021 Long-Term Incentive Plan to increase the number of shares of common stock reserved for issuance under the plan.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 64.8% support
Ovid Therapeutics Inc.2025-07-092 wordings Election of Class II directors: Kevin FitzgeraldWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 75.6% support
Hyster-Yale, Inc.2026-05-12Election of Directors: Alfred M. Rankin, Jr.WithholdFOR — 5 of 5 Equitable fundsAgainstElected, 94.2% support
Hyster-Yale, Inc.2026-05-12Election of Directors: Ann A. O'HaraWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 99.5% support
Hyster-Yale, Inc.2026-05-12Election of Directors: Britton T. TaplinWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 98.6% support
Hyster-Yale, Inc.2026-05-12Election of Directors: Carolyn CorviWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 94.1% support
Hyster-Yale, Inc.2026-05-12Election of Directors: Claiborne R. RankinWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 94.6% support
Hyster-Yale, Inc.2026-05-12Election of Directors: Colleen R. BatchelerWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 95.0% support
Hyster-Yale, Inc.2026-05-12Election of Directors: David B.H. WilliamsWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 94.6% support
Hyster-Yale, Inc.2026-05-12Election of Directors: Edward T. EliopoulosWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 99.2% support
Hyster-Yale, Inc.2026-05-12Election of Directors: Gary L. CollarWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 99.3% support
Hyster-Yale, Inc.2026-05-12Election of Directors: H. Vincent PoorWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 94.7% support
Hyster-Yale, Inc.2026-05-12Election of Directors: James B. BemowskiWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 99.5% support
Hyster-Yale, Inc.2026-05-12Election of Directors: John P. JumperWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 94.1% support
DiaMedica Therapeutics Inc.2026-05-20To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until their respective successors are elected and qualified: Michael Giuffre, M.D.WithholdFOR — 5 of 5 Equitable fundsAgainstElected, 97.8% support
Ooma, Inc.2026-06-04To elect two Class II directors to hold office until the 2029 annual meeting of stockholders or until their respective successors are elected and qualified: Russ MannWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 94.9% support
Ooma, Inc.2026-06-04To elect two Class II directors to hold office until the 2029 annual meeting of stockholders or until their respective successors are elected and qualified: Susan G. ButenhoffWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 67.1% support
American Coastal Insurance Corporation2026-05-264 wordings Election of Directors To be elected for terms expiring in 2028: Alec L. Poitevint, II Class B NomineeAbstainFOR — 5 of 5 Equitable fundsAgainstElected, 99.2% support
W&T Offshore, Inc.2026-06-03To amend the Company's 2023 Incentive Compensation Plan to increase the number of shares of the Company's common stock available for issuance thereunder from 10,000,000 to 22,000,000.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 81.2% support
Concrete Pumping Holdings, Inc.2026-04-15To elect the four Class II Director nominees: Brian HodgesWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.0% support
Concrete Pumping Holdings, Inc.2026-04-15To elect the four Class II Director nominees: Howard D. MorganWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 84.9% support
Concrete Pumping Holdings, Inc.2026-04-15To elect the four Class II Director nominees: John M. PiecuchWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 94.0% support
Concrete Pumping Holdings, Inc.2026-04-15To elect the four Class II Director nominees: Raymond CheesmanWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.0% support
Rimini Street, Inc.2026-06-03Election of Class III Directors: Jay SnyderWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 86.3% support
Rimini Street, Inc.2026-06-03Election of Class III Directors: Seth A. RavinWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.5% support
Home Bancorp, Inc.2026-05-12Election of Directors: Three-year term expiring in 2029: Chris P. RaderWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 93.6% support
Home Bancorp, Inc.2026-05-12Election of Directors: Two-year term expiring in 2028: Daniel G. GuidryWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.0% support
Solid Power, Inc.2026-05-20Approval, by a non-binding advisory vote, of the compensation of Solid Power, Inc.'s named executive officers.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 84.9% support
Solid Power, Inc.2026-05-20Election of three Class II Directors: Aleksandra MiziolekWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 84.1% support
Solid Power, Inc.2026-05-20Election of three Class II Directors: MaryAnn WrightWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 95.9% support
Solid Power, Inc.2026-05-20Election of three Class II Directors: Steven GoldbergWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 87.8% support
Monopar Therapeutics Inc.2026-06-22Election of Directors: Christopher M. StarrForWITHHOLD — 5 of 5 Equitable fundsForElected, 84.7% support
Monopar Therapeutics Inc.2026-06-22Election of Directors: Raymond W. AndersonForWITHHOLD — 5 of 5 Equitable fundsForElected, 94.2% support
Monopar Therapeutics Inc.2026-06-22To approve the compensation of our named executive officers on an advisory, non-binding basis.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 87.8% support
Shattuck Labs, Inc.2025-07-10To elect the three Class II director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: George Golumbeski, Ph.D.WithholdFOR — 5 of 5 Equitable fundsAgainstElected, 94.7% support
Shattuck Labs, Inc.2025-07-10To elect the three Class II director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Neil Gibson, Ph.D.WithholdFOR — 5 of 5 Equitable fundsAgainstElected, 92.6% support
Dine Brands Global, Inc.2026-05-14Shareholder A stockholder proposal regarding the right of stockholders to call a special meeting of stockholders at a 15% ownership threshold.ForAGAINST — 5 of 5 Equitable fundsAgainstNot approved, 44.2% support
Dine Brands Global, Inc.2026-05-14Approval, on an advisory basis, to provide stockholders the right to call a special meeting of the stockholders at a 25% ownership threshold.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 71.1% support
Hamilton Beach Brands Holding Company2026-05-07Election of Directors: Alfred M. Rankin, Jr.ForWITHHOLD — 5 of 5 Equitable fundsForElected, 95.7% support
Hamilton Beach Brands Holding Company2026-05-07Election of Directors: J.C. Butler, Jr.ForWITHHOLD — 5 of 5 Equitable fundsForElected, 95.1% support
Hamilton Beach Brands Holding Company2026-05-07Election of Directors: James A. RatnerWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 97.2% support
Hamilton Beach Brands Holding Company2026-05-07Election of Directors: Mark R. BelgyaWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 97.9% support
Hamilton Beach Brands Holding Company2026-05-07Election of Directors: Michael S. MillerWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 97.2% support
Hamilton Beach Brands Holding Company2026-05-07Election of Directors: Paul D. FurlowWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 97.9% support
Consolidated Water Co. Ltd.2026-06-01The approval of an Ordinary Resolution, attached as Exhibit A to the Proxy Statement, authorizing an increase of the share capital of the Company from (i) CI$12.5 million divided into 24,800,000 Ordinary Shares of par value CI$0.50 each and 200,000 Redeemable Preference Shares of par value CI$0.50 eAgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 95.1% support
Aspen Aerogels, Inc.2026-05-13Approval, on a non-binding, advisory basis, of the compensation of Aspen Aerogels, Inc.'s named executive officers, as disclosed in its Proxy Statement for the 2026 Annual Meeting.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 87.1% support
Aspen Aerogels, Inc.2026-05-13Election of Directors: Donald R. YoungWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 90.4% support
Aspen Aerogels, Inc.2026-05-13Election of Directors: Steven R. MitchellWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 89.3% support
Boston Omaha Corporation2025-08-25Election of Directors (other than the Class B common stock Director): Jeffrey C. RoyalWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 97.1% support
Shoe Carnival, Inc.2026-06-10Election of Directors: Diane E. RandolphAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 89.3% support
Shoe Carnival, Inc.2026-06-10Election of Directors: J. Wayne WeaverAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 98.7% support
Citizens Financial Services, Inc.2026-04-21Advisory vote to approve the compensation of the Company's named executive officers as disclosed in the proxy statement.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 82.6% support
Citizens Financial Services, Inc.2026-04-21Election of Class 3 Directors: Janie M. HilfigerWithholdFOR — 5 of 5 Equitable fundsAgainst—
Citizens Financial Services, Inc.2026-04-21Election of Class 3 Directors: Rinaldo A. DePaolaWithholdFOR — 5 of 5 Equitable fundsAgainst—
Telos Corporation2026-05-07ELECTION OF DIRECTORS: To elect seven Directors to the Board of Directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: David BorlandForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 80.5% support
Rezolute, Inc.2025-11-19To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers as disclosed in the Executive Compensation section of the Proxy Statement.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 67.7% support
Rezolute, Inc.2025-11-19To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Gil LabrucherieForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 93.2% support
Rezolute, Inc.2025-11-19To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Nerissa KreherWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 76.6% support
Stitch Fix, Inc.2025-12-11Election of Directors: Kofi Amoo-GottfriedWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 91.6% support
Stitch Fix, Inc.2025-12-11Election of Directors: Timothy BaxterWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 93.8% support
Regional Management Corp.2026-05-14Re-approval of the Regional Management Corp. 2024 Long-Term Incentive Plan (as amended and restated effective as of May 14, 2026).AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 83.7% support
Designer Brands Inc.2026-06-17Amend the provisions relating to director and officer indemnification and related matters.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 83.9% support
Designer Brands Inc.2026-06-17Election of Directors: Harvey L. SonnenbergWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 99.0% support
Designer Brands Inc.2026-06-17Election of Directors: Peter S. CobbWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 90.0% support
Flexsteel Industries, Inc.2025-12-10To elect two (2) Class III Directors to serve until the 2028 Annual Meeting and until their respective successors have been elected and qualified or until their earlier resignation, removal or termination: M. Scott CulbrethWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.3% support
First Community Corporation2025-11-19To consider and vote on a proposal to authorize the board of directors to adjourn the special meeting, if necessary or appropriate, to allow time for further solicitation of proxies in the event there are insufficient votes present at the special meeting, in person or by proxy, to approve the First AbstainFOR — 5 of 5 Equitable fundsAgainst—
First Community Corporation2025-11-19To consider and vote upon a proposal to approve the Agreement and Plan of Merger dated as of July 13, 2025, by and among First Community Corporation, First Community Bank, and Signature Bank of Georgia, under which Signature Bank will be merged with and into First Community Bank, and the transactionAbstainFOR — 5 of 5 Equitable fundsAgainst—
Titan International, Inc.2026-06-18To elect the following directors to serve for one-year terms and until their successors are elected and qualified: Maurice M. Taylor, Jr.ForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 91.8% support
Titan International, Inc.2026-06-18To elect the following directors to serve for one-year terms and until their successors are elected and qualified: Max A. GuinnForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 87.0% support
First Western Financial, Inc.2026-06-03Advisory, non-binding vote to approve the compensation paid to the Company's named executive officers.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 80.0% support
First Western Financial, Inc.2026-06-03Election of Directors: David R. DuncanWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.7% support
First Western Financial, Inc.2026-06-03Election of Directors: Julie A. CaponiWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.0% support
First Western Financial, Inc.2026-06-03Election of Directors: Patrick H. HamillWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 94.7% support
Princeton Bancorp, Inc.2026-04-21the election of nine directors to the Company's board of directors, each to serve until the 2027 Annual Meeting of shareholders, and until his or her successor is elected and qualified: Judith A. GiacinWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 83.0% support
Princeton Bancorp, Inc.2026-04-21the election of nine directors to the Company's board of directors, each to serve until the 2027 Annual Meeting of shareholders, and until his or her successor is elected and qualified: Richard J. GillespieWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 82.5% support
Princeton Bancorp, Inc.2026-04-21the election of nine directors to the Company's board of directors, each to serve until the 2027 Annual Meeting of shareholders, and until his or her successor is elected and qualified: Robert N. RidolfiWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 82.9% support
Turtle Beach Corporation2026-06-02Election of Directors: Julia W. SzeAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 92.9% support
Turtle Beach Corporation2026-06-02Election of Directors: William WyattAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 91.5% support
Enanta Pharmaceuticals, Inc.2026-03-11To approve an amendment to our 2019 Equity Incentive Plan.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 78.4% support
Enanta Pharmaceuticals, Inc.2026-03-11To elect two Class I directors to serve until the 2029 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Bruce L.A. Carter, Ph.D.WithholdFOR — 5 of 5 Equitable fundsAgainstElected, 81.4% support
Hawthorn Bancshares, Inc.2026-06-02ELECTION OF FOUR CLASS I DIRECTORS: Douglas T. EdenAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.9% support
Fulcrum Therapeutics, Inc.2026-06-24Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Alan EzekowitzWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 97.3% support
Fulcrum Therapeutics, Inc.2026-06-24Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Colin HillWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 97.3% support
Fulcrum Therapeutics, Inc.2026-06-24Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Sonja BanksWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 80.3% support
3D Systems Corporation2026-05-14The election of the nine directors named in the accompanying Proxy Statement: Charles G. McClure, Jr.AgainstFOR — 5 of 5 Equitable fundsAgainstElected, 92.3% support
3D Systems Corporation2026-05-14The election of the nine directors named in the accompanying Proxy Statement: Claudia N. DraytonAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 90.5% support
3D Systems Corporation2026-05-14The election of the nine directors named in the accompanying Proxy Statement: Jeffrey A. GravesAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 92.3% support
3D Systems Corporation2026-05-14The election of the nine directors named in the accompanying Proxy Statement: Jim D. KeverAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 92.2% support
3D Systems Corporation2026-05-14The election of the nine directors named in the accompanying Proxy Statement: John J. TracyAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 91.9% support
3D Systems Corporation2026-05-14The election of the nine directors named in the accompanying Proxy Statement: Kevin S. MooreAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 91.7% support
3D Systems Corporation2026-05-14The election of the nine directors named in the accompanying Proxy Statement: Malissia R. ClintonAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 90.3% support
3D Systems Corporation2026-05-14The election of the nine directors named in the accompanying Proxy Statement: Thomas W. EricksonAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 91.8% support
3D Systems Corporation2026-05-14The election of the nine directors named in the accompanying Proxy Statement: Vasant PadmanabhanAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 91.0% support
Perma-Fix Environmental Services, Inc.2025-07-24ELECTION OF DIRECTORS: Joe R. ReederWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 94.7% support
The E.W. Scripps Company2026-05-04Election of Directors: Burton F. JablinWithholdFOR — 5 of 5 Equitable fundsAgainst—
The E.W. Scripps Company2026-05-04Election of Directors: Kim WilliamsWithholdFOR — 5 of 5 Equitable fundsAgainst—
The E.W. Scripps Company2026-05-04Election of Directors: Marcellus W. Alexander, Jr.WithholdFOR — 5 of 5 Equitable fundsAgainst—
The E.W. Scripps Company2026-05-04Election of Directors: Nishat A. MehtaWithholdFOR — 5 of 5 Equitable fundsAgainst—
Acme United Corporation2026-04-27Approval of an amendment to the 2022 Employee Stock Option Plan to increase the number of shares authorized for issuance as described in the Proxy Statement.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 67.8% support
Friedman Industries, Incorporated2025-09-18Election of Directors: J. WilliamsForWITHHOLD — 5 of 5 Equitable fundsForElected, 88.3% support
M-tron Industries, Inc.2026-06-16To approve the Second Amended and Restated M-tron Industries, Inc. 2022 Incentive Plan.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 72.4% support
M-tron Industries, Inc.2026-06-16To elect seven (7) directors to serve until the 2027 annual meeting of stockholders: John MegaForWITHHOLD — 5 of 5 Equitable fundsForElected, 84.5% support
M-tron Industries, Inc.2026-06-16To elect seven (7) directors to serve until the 2027 annual meeting of stockholders: Marc GabelliWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 72.7% support
iHeartMedia, Inc.2026-06-04The approval of the second amendment to the iHeartMedia, Inc. 2021 Long-Term Incentive Award Plan.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.7% support
iHeartMedia, Inc.2026-06-04The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 84.4% support
iHeartMedia, Inc.2026-06-04The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Cheryl MillsWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 92.3% support
iHeartMedia, Inc.2026-06-04The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Graciela MonteagudoWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.8% support
iHeartMedia, Inc.2026-06-04The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: James A. RasuloWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 90.7% support
iHeartMedia, Inc.2026-06-04The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Kamakshi SivaramakrishnanWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.8% support
iHeartMedia, Inc.2026-06-04The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Richard J. BresslerWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.8% support
iHeartMedia, Inc.2026-06-04The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Robert MillardWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 92.7% support
iHeartMedia, Inc.2026-06-04The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Robert W. PittmanWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.7% support
iHeartMedia, Inc.2026-06-04The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Samuel E. EnglebardtWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 92.7% support
Richardson Electronics, Ltd.2025-10-07Election of directors: Jacques BelinWithholdFOR — 5 of 5 Equitable fundsAgainst—
Richardson Electronics, Ltd.2025-10-07Election of directors: James BenhamWithholdFOR — 5 of 5 Equitable fundsAgainst—
Richardson Electronics, Ltd.2025-10-07Election of directors: Kenneth HalversonWithholdFOR — 5 of 5 Equitable fundsAgainst—
Richardson Electronics, Ltd.2025-10-07Election of directors: Robert KlugeWithholdFOR — 5 of 5 Equitable fundsAgainst—
Richardson Electronics, Ltd.2025-10-07To approve an amendment to the Amended and Restated 2011 Long-Term Incentive Plan to increase the number of shares available for issuance under the Plan.AgainstFOR — 5 of 5 Equitable fundsAgainst—
Standard BioTools Inc.2026-06-17Election of Directors: Eli CasdinWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 94.0% support
Standard BioTools Inc.2026-06-17Election of Directors: Thomas CareyWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 91.2% support
Standard BioTools Inc.2026-06-17To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 85.2% support
Lifecore Biomedical, Inc.2025-10-29To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Humberto C. AntunesAbstainFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 99.0% support
Lifecore Biomedical, Inc.2025-10-29To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Matthew E. KorenbergAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 94.6% support
Lifecore Biomedical, Inc.2025-10-29To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Nelson ObusAbstainFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 97.9% support
Lifecore Biomedical, Inc.2026-06-04To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Humberto C. AntunesAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 93.9% support
Lifecore Biomedical, Inc.2026-06-04To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Joshua E. SchechterAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 88.2% support
Lifecore Biomedical, Inc.2026-06-04To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Matthew E. KorenbergAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 92.7% support
Lifecore Biomedical, Inc.2026-06-04To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Nelson ObusAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 92.8% support
Lifecore Biomedical, Inc.2026-06-04To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Paul H. JohnsonAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 94.8% support
Medallion Financial Corp.2026-06-09Shareholder ELECTION OF DIRECTORS - TO ELECT THREE (3) CLASS III DIRECTORS, EACH FOR A TERM EXPIRING AT THE 2029 ANNUAL MEETING OF STOCKHOLDERS ZIMCAL ASSET MANAGEMENT LLC, NOMINEES: Eric KellyForWITHHOLD — 5 of 5 Equitable fundsAgainstPlurality election, 19.5% support
Medallion Financial Corp.2026-06-09ELECTION OF DIRECTORS - TO ELECT THREE (3) CLASS III DIRECTORS, EACH FOR A TERM EXPIRING AT THE 2029 ANNUAL MEETING OF STOCKHOLDERS COMPANY NOMINEES: Cynthia HallenbeckWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 75.9% support
RCM Technologies, Inc.2025-12-18Approve our 2025 Omnibus Equity Compensation Plan.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 64.9% support
RCM Technologies, Inc.2025-12-18Election of four directors proposed in the accompanying proxy, each to serve one-year term and until a successor is elected and qualified: Swarna Srinivas KakodkarForAGAINST — 5 of 5 Equitable fundsForPassed (calculated), 95.0% support
Zumiez Inc.2026-06-03Election of Directors: Carmen R. BauzaAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 97.1% support
Zumiez Inc.2026-06-03Election of Directors: Liliana Gil VallettaAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 99.2% support
Zumiez Inc.2026-06-03Election of Directors: Thomas D. CampionAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 96.5% support
OP Bancorp2026-05-28Election of Directors Elect 7 directors to serve one-year terms expiring in 2027: Yong Sin ShinForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 92.2% support
Immersion Corporation2026-04-06Election of five (5) directors: Eric SingerWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 91.0% support
Immersion Corporation2026-04-06Election of five (5) directors: Frederick WaschWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 87.8% support
Korro Bio, Inc.2026-06-10Election of two Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Nessan BerminghamForWITHHOLD — 5 of 5 Equitable fundsForElected, 82.6% support
Vanda Pharmaceuticals Inc.2026-06-04To elect three Class II Directors: Anne Sempowski WardAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 88.2% support
Vanda Pharmaceuticals Inc.2026-06-04To elect three Class II Directors: Richard W. DuganAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 85.9% support
SIGA Technologies, Inc.2026-06-09Election of Directors: Gary J. NabelForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 91.5% support
SIGA Technologies, Inc.2026-06-09Election of Directors: Joseph W. Marshall, IIIForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 89.2% support
Protalix Biotherapeutics, Inc.2026-06-25To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement that accompanies this notice;AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 80.9% support
Pro-Dex, Inc.2025-11-20Election of Directors: David C. HovdaForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 91.4% support
Pro-Dex, Inc.2025-11-20Election of Directors: Katrina M.K. PhilpForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 92.0% support
Pro-Dex, Inc.2025-11-20To amend the 2016 Equity Incentive Plan in order to extend its term for an additional ten years.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 92.3% support
Meridian Corporation2026-05-28ELECTION OF DIRECTORS. The election of three (3) directors as "Class C" directors of the Board, to serve a three-year term expiring in 2029: Edward J. HollinWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 78.5% support
Alta Equipment Group Inc.2026-05-29Election of Directors: Colin WilsonWithholdFOR — 5 of 5 Equitable fundsAgainst—
Alta Equipment Group Inc.2026-05-29Election of Directors: Ryan GreenawaltWithholdFOR — 5 of 5 Equitable fundsAgainst—
Westwood Holdings Group, Inc.2026-04-30To approve the Twelfth Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 85.9% support
Nature's Sunshine Products, Inc.2026-05-06To approve the adoption of the Nature's Sunshine Products, Inc. 2026 Stock Incentive Plan.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 52.6% support
Hudson Technologies, Inc.2026-06-10To elect a class of four directors to the Board of Directors: Eric A. ProutyWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 93.9% support
Hudson Technologies, Inc.2026-06-10To elect a class of four directors to the Board of Directors: Loan N. MansyWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 93.4% support
Hudson Technologies, Inc.2026-06-10To elect a class of four directors to the Board of Directors: Richard ParrilloWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 93.8% support
Crexendo, Inc.2025-12-02To consider and vote upon a proposal for advisory approval of the compensation of the Company's named executive officers;AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 91.5% support
Crexendo, Inc.2025-12-02a proposal to elect six (6) directors nominated by our board of directors and named in this proxy statement: Kevin JacksonWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 94.4% support
Crexendo, Inc.2025-12-02a proposal to elect six (6) directors nominated by our board of directors and named in this proxy statement: Steven G. MihayloWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 94.0% support
The Eastern Company2026-05-06Election of Directors: James A. MitarotondaForAGAINST — 5 of 5 Equitable fundsFor—
Epsilon Energy Ltd.2025-11-12To adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for the approval of the Share Issuance Proposal (the "Adjournment Proposal").AbstainFOR — 5 of 5 Equitable fundsAgainstApproved, 82.4% support
Epsilon Energy Ltd.2025-11-12To approve the issuance of Common Shares pursuant to the Purchase Agreements, for purposes of complying with NASDAQ Listing Rule 5635 (the "Share Issuance Proposal").AbstainFOR — 5 of 5 Equitable fundsAgainst—
Epsilon Energy Ltd.2026-05-20Election of Directors: Bryan LawrenceWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 95.8% support
Epsilon Energy Ltd.2026-05-20Election of Directors: David WinnWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 99.3% support
Epsilon Energy Ltd.2026-05-20Election of Directors: John LovoiForWITHHOLD — 5 of 5 Equitable fundsForElected, 93.6% support
Epsilon Energy Ltd.2026-05-20Election of Directors: Tracy StephensForWITHHOLD — 5 of 5 Equitable fundsForElected, 89.2% support
Energy Services of America Corporation2026-02-18Election of Directors: Joseph L. WilliamsForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 87.9% support
eGain Corporation2025-12-09Approval of the election of each of the nominated directors to serve until the 2026 annual meeting of stockholders or until their successors are elected and qualified: Gunjan SinhaForWITHHOLD — 5 of 5 Equitable fundsForElected, 69.7% support
DMC Global Inc.2026-05-13Election of Directors: Michael A. KellyWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 77.4% support
DMC Global Inc.2026-05-13Election of Directors: Ouma SananikoneWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 75.3% support
DMC Global Inc.2026-05-13Election of Directors: Ruth I. DreessenWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 78.0% support
Medifast, Inc.2026-05-19Approve the Amended and Restated 2012 Share Incentive Plan.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 68.9% support
Medifast, Inc.2026-05-19Approve, on an advisory basis, the compensation of the Company's named executive officers.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 86.2% support
Medifast, Inc.2026-05-19Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Scott SchlackmanForAGAINST — 5 of 5 Equitable fundsForElected, 82.8% support
Mammoth Energy Services, Inc.2026-06-25Election of Directors: James PalmForAGAINST — 5 of 5 Equitable fundsForElected, 92.0% support
KORU Medical Systems, Inc.2026-05-19Approval of an amendment to the 2024 Omnibus Equity Incentive Plan to increase the available number of shares.AgainstFOR — 5 of 5 Equitable fundsAgainst—
Quanterix Corporation2025-09-29Election of three director nominees to our Board to serve three-year terms expiring at the annual meeting of stockholders in 2028 or until their successors are duly elected and qualified: David R. Walt, Ph.D.WithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 82.8% support
Protara Therapeutics, Inc.2026-06-12Approval of an amendment to the Protara Therapeutics, Inc. 2024 Equity Incentive PlanAgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 58.6% support
Protara Therapeutics, Inc.2026-06-12Election of three Class III directors to the Board of Directors of Protara Therapeutics, Inc., each to hold office until the annual meeting of stockholders in 2029: Barry Flannelly, Pharm.D.WithholdFOR — 5 of 5 Equitable fundsAgainstElected, 82.2% support
Compass Therapeutics, Inc.2026-06-10To elect two class III directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal: Richard S. Lindahl, M.B.A.WithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 84.9% support
enCore Energy Corp.2026-06-10To elect seven directors for the ensuing year: Nathan A. TewaltWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 98.5% support
enCore Energy Corp.2026-06-10To elect seven directors for the ensuing year: Susan Hoxie-KeyWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 64.2% support
enCore Energy Corp.2026-06-10To elect seven directors for the ensuing year: William B. HarrisWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 97.8% support
Ascent Industries Co.2026-06-10Election of Directors: Aldo J. MazzaferroForAGAINST — 5 of 5 Equitable fundsForPassed (calculated), 64.8% support
Akebia Therapeutics, Inc.2026-06-17Election of three Class III Directors to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: LeAnne M. ZumwaltWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 68.3% support
Coherus Oncology, Inc.2026-05-29To approve an increase in the number of shares of our common stock reserved for issuance under the Amended and Restated 2014 Equity Incentive Award Plan.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 70.5% support
Coherus Oncology, Inc.2026-05-29To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Dennis M. LanfearWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 92.7% support
Coherus Oncology, Inc.2026-05-29To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Mats L. WahlstromWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 91.2% support
Foghorn Therapeutics Inc.2026-06-242 wordings Elect Class III directors each for a three-year term: Balkrishan (Simba) Gill, Ph.D.AgainstFOR — 5 of 5 Equitable fundsAgainstElected, 99.7% support
SoundThinking, Inc.2026-06-03Election of Class III Directors: Marc MorialWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 87.1% support
SoundThinking, Inc.2026-06-03Election of Class III Directors: Ralph A. ClarkWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.8% support
SoundThinking, Inc.2026-06-03Election of Class III Directors: Ruby SharmaWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.6% support
Humacyte, Inc.2026-06-09Approval, on an advisory basis, of the compensation paid to Humacyte, Inc.'s named executive officers.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 67.3% support
Humacyte, Inc.2026-06-09Election of three Class II directors to serve until the 2029 annual meeting of stockholders: Kathleen SebeliusWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 84.7% support
Humacyte, Inc.2026-06-09Election of three Class II directors to serve until the 2029 annual meeting of stockholders: Keith Anthony JonesWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 84.9% support
Stereotaxis, Inc.2026-05-14To elect each of the following directors to serve a three-year term as a Class I director until the 2029 Annual Meeting and until their respective successors are duly elected and qualified: Dr. Myriam CuretAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.4% support
Stereotaxis, Inc.2026-05-14To elect each of the following directors to serve a three-year term as a Class I director until the 2029 Annual Meeting and until their respective successors are duly elected and qualified: Mr. David BenferAgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 97.5% support
Atomera Incorporated2026-05-12To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement to be filed for the Annual Meeting.AgainstFOR — 5 of 5 Equitable fundsAgainst—
Virco Mfg. Corporation2026-06-16Election of two class I Directors: Craig L. LevraWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 83.2% support
Virco Mfg. Corporation2026-06-16Election of two class I Directors: Robert R. LindWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.6% support
Lakeland Industries, Inc.2026-06-16Elect three directors to serve for a term of three years or until their successors have been duly elected and qualified: Melissa KiddWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 92.8% support
Lakeland Industries, Inc.2026-06-16Elect three directors to serve for a term of three years or until their successors have been duly elected and qualified: Ronald HerringWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 96.7% support
Rithm Property Trust Inc.2026-06-02Election of Directors: Mary HaggertyForWITHHOLD — 5 of 5 Equitable fundsForPassed (calculated), 51.7% support
Rithm Property Trust Inc.2026-06-02Election of Directors: Paul FriedmanWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 53.1% support
Rithm Property Trust Inc.2026-06-02To approve (on a non-binding advisory basis) the compensation of the named executive officers as described in the accompanying materials.AgainstFOR — 5 of 5 Equitable fundsAgainstNot approved, 30.7% support
Outset Medical, Inc.2026-06-04Election of Class III Directors: Brent D. LangWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 75.4% support
Outset Medical, Inc.2026-06-04To approve, on a non-binding basis, the 2025 compensation of our named executive officers.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 70.2% support
Siebert Financial Corp.2025-11-18Advisory vote to approve named executive compensation.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.5% support
BARK, Inc.2026-03-25Approve, on an advisory basis, the compensation of the company's named executive officers.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 81.1% support
BARK, Inc.2026-03-25Elect the two Class A director nominees named in the proxy statement: Betsy McLaughlinWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 84.3% support
BARK, Inc.2026-03-25Elect the two Class A director nominees named in the proxy statement: Henrik WerdelinWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 89.3% support
TTEC Holdings, Inc.2026-05-21Election of Director Nominees: Gregory A. ConleyForWITHHOLD — 5 of 5 Equitable fundsForElected, 96.5% support
TTEC Holdings, Inc.2026-05-21Election of Director Nominees: Robert N. FrerichsWithholdFOR — 5 of 5 Equitable fundsAgainstElected, 89.9% support
TTEC Holdings, Inc.2026-05-21The approval of the redomestication of the Company from Delaware to Texas by conversion.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 85.7% support
SelectQuote, Inc.2025-11-11To elect the Class III director nominees listed below for a term of three years: Denise L. DevineWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 78.7% support
SelectQuote, Inc.2025-11-11To elect the Class III director nominees listed below for a term of three years: Donald L. Hawks IIIWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 81.8% support
SkinHealth Systems Inc.2026-06-10Election of Directors: Brian MillerForWITHHOLD — 5 of 5 Equitable fundsForElected, 78.6% support
LENSAR, Inc.2025-12-18Election of Class II Directors: Aimee S. WeisnerWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 92.6% support
KULR Technology Group, Inc.2025-11-21Proposal to adopt the "KULR Technology Group, Inc., 2025 Equity Incentive Plan."AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 98.4% support
Heron Therapeutics, Inc.2026-06-11To approve the amendment and restatement of the Company's 2007 Amended and Restated Equity Incentive Plan, to, among other things, increase the number of shares of common stock authorized for issuance thereunder by an additional 16,560,000 shares.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 84.5% support
Travelzoo2026-04-20To elect five members of the Company's Board of Directors (the "Board"), each to serve until the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified or until their earlier resignation or removal: Volodymyr CherevkoForAGAINST — 5 of 5 Equitable fundsForPassed (calculated), 93.8% support
Myomo, Inc.2026-06-25Elect two Class III directors, namely Paul R. Gudonis and Thomas F. Kirk, each to hold office until the 2029 annual meeting of stockholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal: Thomas F. KirkWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 92.9% support
Myomo, Inc.2026-06-25To approve any adjournments and postponements of the Annual Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the Annual Meeting to approve Proposals 1-6; andForAGAINST — 5 of 5 Equitable fundsForApproved, 84.7% support
Skillsoft Corp.2026-06-25To approve, on an advisory basis, the compensation of our named executive officers;ForAGAINST — 5 of 5 Equitable fundsForPassed (calculated), 86.3% support
Skillsoft Corp.2026-06-25To elect as directors the three nominees named in the accompanying Proxy Statement to a term of three years each, or until their successors have been elected and qualified: Michael S. KleinWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 92.8% support
SANUWAVE Health, Inc.2025-08-19Election of Directors: James TylerWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 95.5% support
SANUWAVE Health, Inc.2025-08-19To approve an amendment to the SANUWAVE Health, Inc. 2024 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by 500,000 shares.AgainstFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 96.1% support
SANUWAVE Health, Inc.2026-06-11Election of Directors: James TylerWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 84.9% support
SANUWAVE Health, Inc.2026-06-11Election of Directors: Jeffrey BlizardWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 91.6% support
eHealth, Inc.2026-06-18Approval of an amendment and restatement of the eHealth, Inc. Amended and Restated 2024 Equity Incentive Plan to Increase the maximum number of shares of common stock that may be issued thereunder by 1,300,000 shares.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 82.3% support
eHealth, Inc.2026-06-18Election of Class II Directors: Beth A. BrookeWithholdFOR — 5 of 5 Equitable fundsAgainstPassed (calculated), 82.3% support
aTyr Pharma, Inc.2026-05-11To elect three Class II directors, as nominated by the Company's Board of Directors (the "Board of Directors"), to hold office until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Jane A. Gross, Ph.D.WithholdFOR — 5 of 5 Equitable fundsAgainst—
Accuray Incorporated2025-11-13To approve our 2026 Equity Incentive Plan.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 87.0% support
Accuray Incorporated2025-11-13To elect three Class I directors named in the accompanying proxy statement to serve until our 2028 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified: Anne B. Le GrandAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 92.0% support
Accuray Incorporated2025-11-13To elect three Class I directors named in the accompanying proxy statement to serve until our 2028 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified: Joseph E. WhittersAgainstFOR — 5 of 5 Equitable fundsAgainstElected, 88.8% support

2,247 more in the CSV.

Download all 2,747 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 90.8% of this fund’s 15,504 such votes could be given a sector; the other 1,433 (9.2%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance3,16130.1%
Consumer Discretionary2,724240.9%
Health Care2,435110.5%
Industrials1,55850.3%
Technology1,41540.3%
Real Estate87810.1%
Energy61500.0%
Utilities37800.0%
Consumer Staples25552.0%
Basic Materials23700.0%
Miscellaneous21000.0%
Telecommunications20510.5%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections10,48023
Say-on-Pay1,8342
Audit-related1,8150
Compensation6320
Corporate Governance44917
Capital Structure2163
Extraordinary Transactions2033
Shareholder Rights and Defenses481
Other110
Other Social Issues30

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Bloom Energy CorporationMay 21, 2026$21M80
agilon health, inc.March 17, 2026$20M20
Guardant Health, Inc.June 17, 2026$10M50
Glaukos CorporationMay 28, 2026$8M40
Nextracker Inc.August 18, 2025$7M50
BridgeBio Pharma, Inc.June 22, 2026$7M70
The Ensign Group, Inc.May 13, 2026$6M60
American Healthcare REIT, Inc.June 24, 2026$6M110

Notable votes against management

MeetingCompanyProposalFundMgmt
March 9, 2026Sanmina CorporationTo consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
April 28, 2026The Brink's CompanyAct upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposalAgainstFor
May 13, 2026ICU Medical, Inc.To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposalForAgainst
May 21, 2026Meritage Homes CorporationShareholder proposal to improve shareholder ability to call for a special shareholder meeting. Shareholder proposalForAgainst
May 4, 2026Asbury Automotive Group, Inc.Stockholder proposal regarding special stockholder meetings. Shareholder proposalForAgainst
December 15, 2025UniFirst CorporationTo elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Arnaud Ajdler Shareholder proposalForAgainst
December 15, 2025UniFirst CorporationTo elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Michael A. Croatti Shareholder proposalForAgainst
May 20, 2026Lumen Technologies, Inc.Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposalForAgainst
May 5, 2026SkyWest, Inc.A shareholder proposal regarding collective bargaining policy. Shareholder proposalForAgainst
April 24, 2026ArcBest CorporationA shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. Shareholder proposalForAgainst
May 12, 2026Group 1 Automotive, Inc.Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. Shareholder proposalForAgainst
June 3, 2026Resideo Technologies, Inc.Shareholder Proposal Regarding Shareholder Right to Act by Written Consent. Shareholder proposalForAgainst

Contested meetings

Meetings with a proxy contest or competing nominees (13 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

15,699 ballot items at 2,029 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, EQ/Small Company Index Portfolio voted at 2,029 shareholder meetings of 1,910 companies, on 15,699 ballot items in all. Where management made a recommendation, the fund followed it on 98.4% of the items and voted against it 55 times. Its most frequent area of disagreement was director elections (23 of its votes against management). It voted on 56 shareholder proposals. It voted FOR the board's own proposals less often than Equitable's funds as a whole (79.1% against 92.5%). It voted differently from most Equitable funds on 2,747 items. 13 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.